Dup15q Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Dup15q Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06353620

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

Recent studies have shown that the aperiodic part of the signal (neuronal avalanches) of electroencephalography (EEG) contains important information about the d…

Italy120 participantsStarted 2024-02-13

Treatment: High Density EEG recording, Rey Complex Figure Test

All recent trials (8 shown)

TerminatedPhase 2

NCT05307679

A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

This study consists of two parts. Part 1 will evaluate the safety, efficacy, and pharmacodynamics of 52-weeks of basmisanil treatment in children and adolescent…

United States, Spain, United Kingdom7 participantsStarted 2022-12-16

Treatment: Basmisanil, Placebo

By InvitationNot Applicable

NCT03836300

Parent and Infant Inter(X)Action Intervention (PIXI)

The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosis…

United States120 participantsStarted 2018-11-30

Treatment: Parent-Infant Inter(X)action Intervention (PIXI)

Dup15q Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

All recent trials (8 shown)

A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

Parent and Infant Inter(X)Action Intervention (PIXI)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

All recent trials (8 shown)

A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

Parent and Infant Inter(X)Action Intervention (PIXI)

Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Dup…

A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup…

A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome

Angelman Syndrome (AS) Biomarker Study

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerab…